Abbvie has called time on its $54 billion offer for Ireland-based Shire, after its board said it would no longer recommend the bid to shareholders.
Abbvie has called time on its $54 billion offer for Ireland-based Shire, after its board said it would no longer recommend the bid to shareholders.